Journal of Medical Oncology and Therapeutics

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +44-7360-538437

Distribution of high risk HPV genotypes in HIV infected women of the Moscow region

12th World Cancer Congress
July 23-25, 2018 | Moscow, Russia

Daria Podcufarova , Lebedeva NN, Enaeva MV, Isaguliants MG and Pronin AYu

N. F. Gamaleya Federal Research Center , Russia Moscow regional center for prevention and control of AIDS and infectious diseases, Russia. Moscow regional perinatal center, Russia

Posters & Accepted Abstracts : J Med Oncl Ther


HIV-infection increases the incidence of squamous intraepithelial lesions ultimately leading to cervical cancer. This study characterized the incidence of SIL and prevalence of high carcinogenic risk types (HR-HPV) types in HIV-positive women in relation to their immune status. Cervical smears of HIV-infected (n=618) and HIV-negative (n=100) women aged 19-62 were subjected to cytological screening (BD SurePathTM) and HPV16/18-specific PCR (Abbott RealTime High-Risk HPV). Of HIV(+)- women, 31% had cervical pathology: HSIL (3%), LSIL (14%), ASC-H (2%), ASC-US (12%). None had cervical cancer. Pathology was not related to immune status: women with CD4- nadir >500 and <500 cells/ul had similar frequencies of ASC-US/ASC-H/LSIL/HSIL. Positivity for HR-HPV types was high among women aged<30, and decreased with age as described. The decrease was dramatic in HIV-negative (21% in aged <30 vs 2% in aged >40 years), and milder in HIV-infected (31% in aged <30 vs 17% in aged >40) (p<0,05). Prevalence of HR-HPV types was higher among HIV(+) than HIV(-)-women, specifically aged >30. HIV(+)- women with lesions were infected with at least one HRHPV: HPV16 (HSIL, ASC-H) or non-HPV16 (LSIL, ASC-US). Women with CD4-nadir <500 cells/ul had highprevalence of HR-HPVs other than HPV16/18. Prevalence of lesions and positivity for HPV16/18 was equal in ART-treated and untreated. We confirm higher prevalence of HR-HPV, specifically HPV16, in HIV-infected compared to healthy women, not directly related to immunosuppression. In HIV-infected women, grieve neoplasia were strongly associated with detection of HPV16, advocating creation of therapeutic HPV16-based vaccines for HIV-infected.


Daria Podcufarova has graduated Russian State Medical University, has a specialty in medical biochemistry and is currently working at N. F. Gamaleya Federal Research Center for Epidemiology & Microbiology. She is studying the diversity of HPV types in human mucosa in norm and pathology.

E-mail: [email protected]

Get the App